Influence of pharmaceutical quality on the bioavailability of active components from Ginkgo biloba preparations

Authors: Kressmann S.1; Biber A.2; Wonnemann M.3; Schug B.3; Blume H.H.3; Muller W.E.4

Source: Journal of Pharmacy and Pharmacology, Volume 54, Number 11, 1 November 2002 , pp. 1507-1514(8)

Publisher: Pharmaceutical Press

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

To be effective, herbal medicinal products are expected to meet comparable standards concerning the assessment of efficacy, safety and biopharmaceutical quality as chemically defined synthetic drugs as food supplements. However, these requirements are often not fulfilled, particularly regarding the characterization of biopharmaceutical properties such as in-vitro dissolution and in-vivo bioavailability. With respect to the relevance of biopharmaceutical quality of herbal medicinal products, two different Ginkgo biloba brands (test product: Ginkgo biloba capsules; reference product: Ginkgold) were analysed for dissolution rates and bioavailability of the most relevant active ingredients. Dissolution rates at pH 1 and 4.5 were determined according to the USP 23. The relative bioavailability of ginkgolide A, ginkgolide B and bilobalide was investigated after single oral administration of 120 mg Ginkgo biloba extract as tablets or capsules. Bioavailability data (area under the curve and peak concentration in plasma) were clearly different and did not show bioequivalence of test and reference products. The slow in-vitro dissolution of the test product resulted in a large decrease in bioavailability. These results indicate for the first time that the pharmaceutical properties of a herbal medicinal product have a significant impact on the rate and extent of drug absorption, and very likely on efficacy in humans.

Document Type: Research article

Affiliations: 1: Department of Pharmacology, University of Frankfurt, Marie-Curie-Str. 9, 60439 Frankfurt/Main, Germany 2: Department of Bioanalytics, Dr Willmar Schwabe GmbH, Willmar-Schwabe-Str. 4, 76227 Karlsruhe, Germany 3: SocraTec R&D, Feldbergstr. 59, 61440 Oberursel, Germany 4: Department of Pharmacology, University of Frankfurt, MarieCurie-Str. 9, 60439 Frankfurt/ Main, Germany

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$38.49 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A